RFG Advisory LLC Acquires 1,141 Shares of Synopsys, Inc. (NASDAQ:SNPS)

RFG Advisory LLC grew its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 33.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,567 shares of the semiconductor company’s stock after buying an additional 1,141 shares during the period. RFG Advisory LLC’s holdings in Synopsys were worth $2,217,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Pacifica Partners Inc. bought a new position in shares of Synopsys during the 3rd quarter worth approximately $25,000. Kieckhefer Group LLC bought a new position in shares of Synopsys in the 4th quarter worth $27,000. Tsfg LLC lifted its holdings in shares of Synopsys by 75.0% in the 3rd quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 24 shares in the last quarter. Hazlett Burt & Watson Inc. lifted its holdings in shares of Synopsys by 40.0% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 20 shares in the last quarter. Finally, Princeton Global Asset Management LLC bought a new position in shares of Synopsys in the 3rd quarter worth $44,000. 85.47% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the sale, the executive now directly owns 1,460 shares of the company’s stock, valued at $738,774.60. This trade represents a 93.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on SNPS. Piper Sandler cut their target price on Synopsys from $670.00 to $655.00 and set an “overweight” rating on the stock in a report on Friday, December 6th. Redburn Atlantic began coverage on Synopsys in a report on Monday, January 13th. They issued a “buy” rating and a $600.00 target price on the stock. Mizuho began coverage on Synopsys in a report on Tuesday, October 22nd. They issued an “outperform” rating and a $650.00 target price on the stock. Berenberg Bank began coverage on Synopsys in a report on Tuesday, October 15th. They issued a “buy” rating and a $660.00 target price on the stock. Finally, Wells Fargo & Company cut their target price on Synopsys from $570.00 to $540.00 and set an “equal weight” rating on the stock in a report on Monday, January 13th. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $641.82.

Synopsys Trading Down 1.0 %

NASDAQ SNPS opened at $546.19 on Friday. The firm has a market capitalization of $84.43 billion, a P/E ratio of 37.62, a PEG ratio of 3.57 and a beta of 1.12. The business has a fifty day simple moving average of $518.17 and a 200 day simple moving average of $524.66. Synopsys, Inc. has a 12 month low of $457.52 and a 12 month high of $629.38.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.